SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis

Area of Science:

• Cell Biology
• Molecular Oncology
• Signal Transduction

Background:

• SnoN (Ski-interacting protein) is a key regulator of TGF-β/Smad and p53 signaling pathways.
• SnoN exhibits dual roles in cancer, acting as both a pro-oncogene and an anti-oncogene.
• Cell density-dependent regulation of SnoN suggests potential crosstalk with the Hippo signaling pathway.

Purpose of the Study:

• To investigate the interaction between SnoN and the Hippo signaling pathway.
• To elucidate the role of SnoN in TAZ regulation and breast cancer progression.
• To understand how tissue architecture and polarity influence SnoN within the Hippo network.

Main Methods:

• Co-immunoprecipitation assays to detect protein-protein interactions.
• Western blotting to assess protein levels and phosphorylation.
• Reporter assays to measure transcriptional activity.
• Cell culture models of breast cancer to evaluate oncogenic functions.

Main Results:

• SnoN directly interacts with Hippo pathway components, inhibiting Lats2 binding to TAZ and preventing TAZ phosphorylation.
• SnoN enhances TAZ transcriptional activity and oncogenic functions, leading to increased TAZ stabilization.
• Downregulation of SnoN reduces TAZ expression and suppresses the malignant progression of breast cancer cells.
• Lats2, activated by Scribble, downregulates SnoN expression, linking tissue polarity to SnoN regulation.

Conclusions:

• SnoN is a crucial modulator of the Hippo signaling pathway, integrating tissue architecture and polarity signals.
• SnoN's interaction with Hippo components, particularly Lats2 and TAZ, is critical for regulating TAZ activity and breast cancer progression.
• Targeting SnoN represents a potential therapeutic strategy for breast cancer by disrupting oncogenic signaling networks.